Previous studies showed that a plasmid encoding a mutated murine BORIS (pmBORIS) DNA vaccine could induce murine CD8+ and CD4+ T lymphocyte responses and exhibited an anti-cancer effect [50, 51]. Here, CD8A is linked to cancer.